Expert Opinion on Emerging Drugs, Volume 29, Issue 1 (2024)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Emerging Drugs, Volume 29, Issue 1 (2024)

See all volumes and issues
Volume 29, 2024 Vol 28, 2023 Vol 27, 2022 Vol 26, 2021 Vol 25, 2020 Vol 24, 2019 Vol 23, 2018 Vol 22, 2017 Vol 21, 2016 Vol 20, 2015 Vol 19, 2014 Vol 18, 2013 Vol 17, 2012 Vol 16, 2011 Vol 15, 2010 Vol 14, 2009 Vol 13, 2008 Vol 12, 2007 Vol 11, 2006 Vol 10, 2005 Vol 9, 2004 Vol 8, 2003 Vol 7, 2002 Vol 6, 2001 Vol 6, 2001 Vol 5, 2000 Vol 4, 1999 Vol 3, 1998 Vol 2, 1997
Download citations Download PDFs Download issue

Editorial

Editorial
How will tovorafenib change our treatment of pediatric low-grade glioma?
Inci Yaman & Eric Bouffet
Pages: 1-3
Published online: 02 Feb 2024
First Page PreviewforHow will tovorafenib change our treatment of pediatric low-grade glioma? | Full Text | References | PDF (153.1 KB) | EPUB
  • 1242 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Review

Review Article
Review of phase 2/3 trials in polymyalgia rheumatica and giant cell arteritis
Pratheeshaa Nageswaran, Saad Ahmed & Hasan Tahir
Pages: 5-17
Published online: 13 Jan 2024
AbstractforReview of phase 2/3 trials in polymyalgia rheumatica and giant cell arteritis | Full Text | References | PDF (1.5 MB) | EPUB
  • 276 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Novel and emerging drugs for the treatment of Crohn’s disease: a review of phase II and III trials
Panu Wetwittayakhlang, Talat Bessissow & Peter L. Lakatos
Pages: 19-34
Published online: 11 Jan 2024
AbstractforNovel and emerging drugs for the treatment of Crohn’s disease: a review of phase II and III trials | Full Text | References | PDF (2 MB) | EPUB
  • 265 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
How promising are the latest monoclonal antibodies targeting amyloid-β for the treatment of early Alzheimer’s disease?
Jordan Beveridge, Eileen Kaniecki, Aniketh Naidu, Bret David Silverglate & George Grossberg
Pages: 35-43
Published online: 12 Jan 2024
AbstractforHow promising are the latest monoclonal antibodies targeting amyloid-β for the treatment of early Alzheimer’s disease? | Full Text | References | PDF (1.2 MB) | EPUB
  • 296 Views
  • 0 CrossRef citations
  • 0Altmetric

Mini-review

Review Article
Emerging drugs for the treatment of irritability associated with autism spectrum disorder
Ahmad Shamabadi, Hanie Karimi, Razman Arabzadeh Bahri, Mohsen Motavaselian & Shahin Akhondzadeh
Pages: 45-56
Published online: 04 Feb 2024
AbstractforEmerging drugs for the treatment of irritability associated with autism spectrum disorder | Full Text | References | PDF (1.3 MB) | EPUB
  • 287 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review Article
Targeting the PACAP-38 pathway is an emerging therapeutic strategy for migraine prevention
Lanfranco Pellesi, Messoud Ashina & Paolo Martelletti
Pages: 57-64
Published online: 12 Feb 2024
AbstractforTargeting the PACAP-38 pathway is an emerging therapeutic strategy for migraine prevention | Full Text | References | PDF (1.5 MB) | EPUB
  • 354 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Cannabinoid treatment for the symptoms of autism spectrum disorder
Adi Aran & Dalit Cayam Rand
Pages: 65-79
Published online: 23 Jan 2024
AbstractforCannabinoid treatment for the symptoms of autism spectrum disorder | Full Text | References | PDF (2.4 MB) | EPUB
  • 264 Views
  • 1 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Emerging drugs for the treatment of benign prostatic hyperplasia: a 2023 update
Joshua Winograd et al.
Review Article | Published online: 6 Jun 2024
Emerging therapies for treatment of agitation, psychosis, or apathy in Alzheimer’s disease
Hui Jue Wang et al.
Review Article | Published online: 1 Jun 2024
Emerging drugs for the treatment of short bowel syndrome
Tristan Frau et al.
Review Article | Published online: 23 May 2024
Aticaprant: (a κ-opioid receptor antagonist) for major depressive disorder
Elliot Hampsey et al.
Review Article | Published online: 8 May 2024
Open Access
View all latest articles